BWS
AMPH icon

Buck Wealth Strategies’s Amphastar Pharmaceuticals AMPH Stock Holding History

Buck Wealth Strategies’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,318
Closed -$1.68M – 73
2024
Q1 		$1.68M Buy
+38,318
New +$1.98M 0.58% 42

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Buck Wealth Strategies's AMPH Position: Q2 2024 in Review

Buck Wealth Strategies sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2024, closing a stake of 38,318 shares — an estimated $1.68M sold.

Buck Wealth Strategies first reported a position in AMPH in Q1 2024 and held it in 1 quarter. The position peaked at $1.68M in Q1 2024. 269 funds tracked by Wall St. Rank hold AMPH as of Q2 2024.

  • Buck Wealth Strategies reported no remaining Amphastar Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Buck Wealth Strategies sold 38,318 Amphastar Pharmaceuticals shares in Q2 2024, an estimated $1.68M.
  • Buck Wealth Strategies first reported a position in Amphastar Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Buck Wealth Strategies's Amphastar Pharmaceuticals position peaked at $1.68M in Q1 2024.
  • 269 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2024.

Based on Buck Wealth Strategies's 13F filing for Q2 2024, filed 15 Aug 2024.